|
6 September, 2024
|
|
Kia ora koutou,
|
We are delighted to send you our first Anaesthetist Bulletin - a new format specifically designed
for you to keep you up to date with all essential information for anaesthetists who work at
MercyAscot.
Please read this issue to hear important updates about:
• Anaesthetic Advisory Group (AAG)
• Risk management of opioid-induced ventilatory impairment (OIVI)
• New Policy for Clinical Opioid Management and Naloxone Use
• Gabapentinoid position statement
• New requirements for prescribed alcohol
• Latest information on medicine supply issues
Ngā mihi,
|
|
Andrew Brant
Chief Medical Officer
|
|
|
|
Andrew Brant
Chair of Anaesthesia Advisory Group
|
|
|
|
|
The AAG is an integral part of the clinical governance model within MercyAscot. It consists of 26
individuals who are nominated MercyAscot staff and anaesthetists. Chaired by Paul Gardiner, this
group serves to:
• represent the views of credentialed anaesthetists in matters pertaining to anaesthesia practice at
MercyAscot
• advise MercyAscot on all matters relevant to anaesthesia practice and perioperative medicine
• recommend best practice and assist in formulating policy relating to the practice of anaesthesia
and perioperative medicine
• provide input into training of anaesthesia technicians
• contribute to the process for evaluation of products and equipment, in conjunction with MercyAscot
management
• provide communications to the wider anaesthetic group via the respective anaesthetic groups
The AAG reports to the Clinical Excellence Committee and is accountable to the Chief Executive Officer
and Board of MercyAscot.
Current AAG Members
Paul Gardiner, Clinical Director (Chair)
Shanaaz Arend, Credentialing Officer / PA to CMO (Secretary)
Andrew Brant, Chief Medical Officer
|
|
